New Diabetes Medication pproved by the FDA

Grunberger Diabetes Institute Diabetes Medications New Diabetes Medication pproved by the FDA
0 Comments

Invokana (canagliflozin) was approved by the FDA on March 29, 2013. It’s a first-in-a-class medication for patients with type 2 diabetes. This once-daily pill works in a totally new way – by forcing the body to lose extra sugar by the way of the kidney by spilling it in the urine. Studies have shown improved blood sugar control without the risk of low sugar reactions. Additional benefit has been weight loss and the ability to combine it with other anti-diabetes drugs. Potential side effect might be genital infections.

Categories:

Related Posts

Diabetes and Endocrinology and Public Health
Dr. George Grunberger of Grunberger Diabetes Institute had the honor of presenting Friday May 28th
What to Know About Zegalogue: A new glucagon rescue
Patients whose diabetes treatment includes insulin will experience hypoglycemic episodes, which occur when most people’s
How to Diagnose a Thyroid Condition
January is Thyroid Awareness Month, so it is only fitting we release an article with